The reality of multiple sclerosis assessment in middle-income countries - Authors' reply

Affiliations

¹ Section of Neuroradiology, Department of Radiology, Hospital Universitari Vall d'Hebron, Autonomous University of Barcelona, Barcelona, Spain. Electronic address: alex.rovira.idi@gencat.cat.
² Division of Neurology, University of British Columbia, Vancouver, British Columbia, Canada.
³ Translational Neuroradiology Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MA, USA.
⁴ Department of Diagnostic and Interventional Neuroradiology, Hannover Medical School, Hannover, Germany.

Comment

Àlex Rovira et al. Lancet Neurol. 2022 Mar.

. 2022 Mar;21(3):215-216.

doi: 10.1016/S1474-4422(22)00041-2.

¹ Section of Neuroradiology, Department of Radiology, Hospital Universitari Vall d'Hebron, Autonomous University of Barcelona, Barcelona, Spain. Electronic address: alex.rovira.idi@gencat.cat.
² Division of Neurology, University of British Columbia, Vancouver, British Columbia, Canada.
³ Translational Neuroradiology Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MA, USA.
⁴ Department of Diagnostic and Interventional Neuroradiology, Hannover Medical School, Hannover, Germany.

No abstract available

Comment on

2021 MAGNIMS-CMSC-NAIMS consensus recommendations on the use of MRI in patients with multiple sclerosis.
Wattjes MP, Ciccarelli O, Reich DS, Banwell B, de Stefano N, Enzinger C, Fazekas F, Filippi M, Frederiksen J, Gasperini C, Hacohen Y, Kappos L, Li DKB, Mankad K, Montalban X, Newsome SD, Oh J, Palace J, Rocca MA, Sastre-Garriga J, Tintoré M, Traboulsee A, Vrenken H, Yousry T, Barkhof F, Rovira À; Magnetic Resonance Imaging in Multiple Sclerosis study group; Consortium of Multiple Sclerosis Centres; North American Imaging in Multiple Sclerosis Cooperative MRI guidelines working group. Wattjes MP, et al. Lancet Neurol. 2021 Aug;20(8):653-670. doi: 10.1016/S1474-4422(21)00095-8. Epub 2021 Jun 14. Lancet Neurol. 2021. PMID: 34139157 Review.
The reality of multiple sclerosis assessment in middle-income countries.
Abramov DM, de Silva DS, Salles TRS, Galhanone PR, Lazarev VV. Abramov DM, et al. Lancet Neurol. 2022 Mar;21(3):215. doi: 10.1016/S1474-4422(22)00042-4. Lancet Neurol. 2022. PMID: 35182501 No abstract available.